ABPI
0
Originally scheduled for autumn 2025, the review will now conclude by June 2025. This decision follows concerns from pharmaceutical businesses about the ...
Originally scheduled for autumn 2025, the review will now conclude by June 2025. This decision follows concerns from pharmaceutical businesses about the ...